Home › Keryx drug for dialysis patients poised to challenge Genzyme
 

Keywords :   


Keryx drug for dialysis patients poised to challenge Genzyme

2014-12-30 21:36:54| Biotech - Topix.net

Greg Madison assumed the role of COO at Keryx Biopharmaceuticals in February, and today he oversees the 50-employee Boston office. With the its newly-approved drug for kidney dialysis patients now being shipped and available to be prescribed, Keryx Biopharmaceuticals is poised to take on one of Genzyme's drugs with sales of about $600 million.

Tags: drug challenge patients poised

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »